Constitutive activation of proto-oncogen protein p21 induces cell cycle arrest in the G1 phase in contact-inhibited vascular endothelial cells

Hypertension Research

Volumn 25, Issue 5, 2002, Pages 773-778

  Suzuki, Etsu ^a   Nishimatsu, Hiroaki ^a   Nagata, Daisuke ^a   Satonaka, Hiroshi ^a   Goto, Atsuo ^a   Omata, Masao ^a   Fujita, Toshiro ^a   Nagai, Ryozo ^a   Hirata, Yasunobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

1 phosphatidylinositol 3 kinase; Cell cycle; Endothelium vascular; Mitogen activated protein kinases; Proto oncogene protein p21 (Ras)

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; DNA; MUTANT PROTEIN; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN P21; PROTEIN P27; RAS PROTEIN; THYMIDINE; HRAS PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE;

ADENOVIRUS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE ACTIVATION; GENE CONSTRUCT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTO ONCOGENE; UMBILICUS; VASCULAR ENDOTHELIUM; VIRUS CELL TRANSFORMATION; VIRUS INFECTION; CELL CULTURE; CELL DIVISION; CONTACT INHIBITION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTAGENESIS; PHYSIOLOGY; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL DIVISION; CELLS, CULTURED; CONTACT INHIBITION; CYCLIN A; CYCLIN D1; ENDOTHELIUM, VASCULAR; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MUTAGENESIS; PROTO-ONCOGENE PROTEINS P21(RAS); S PHASE; UMBILICAL VEINS;

EID: 0036747150     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.773     Document Type: Article

References (29)

1. Mokuno S, Ito T, Numaguchi Y, et al: Impaired nitric oxide production and enhanced autoregulation of coronary circulation in young spontaneously hypertensive rats at prehypertensive stage. Hypertens Res 2001 ; 24: 395-401.
2. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
3. Pines J: Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 1995; 308: 697-711.
4. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149-1163.
5. El-Deiry WS, Tokino T, Velculescu VE, et al: WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
6. kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995; 9: 639-649.
7. kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59-66.
8. kip1. Mot Cell Biol 1997; 17: 3850-3857.
9. kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH3T3 fibroblasts. Mol Cell Biol 1997; 17: 5348-5358.
10. Cowley S, Paterson H, Kemp P, Marshall CJ: Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994; 77: 841-852.
11. Mansour SJ, Matten WT, Hermann AS, et al: Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 1994; 265: 966-970.
12. Pedram A, Razandi M, Levin ER: Extracellular signal-regulated kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 1998; 273: 26722-26728.
13. Suzuki E, Nagata D, Yoshizumi M, et al: Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor: possible involvement of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 2000; 275: 3637-3644.
14. Suzuki E, Nagata D, Kakoki M, et al: Molecular mechanisms of endothelin-1-induced cell-cycle progression: involvement of extracellular signal-regulated kinase, protein kinase C and phosphatidylinositol 3-kinase at distinct points. Circ Res 1999; 84: 611-619.
15. Miyake S, Makimura M, Kanegae Y, et al: Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996; 93: 1320-1324.
16. Nagata D, Hirata Y, Suzuki E, et al: Hypoxia-induced adrenomedullin production in the kidney. Kidney Int 1999; 55: 1259-1267.
17. Nagata D, Suzuki E, Nishimatsu H, et al: Cyclin A downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells. Circ Res 2000; 87: 699-704.
18. Newbold RF, Overell RW: Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature 1983; 304: 648-651.
19. Bar-Sagi D, Feramisco JR: Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 1985; 42: 841-848.
20. Benito M, Porras A, Nebreda AR, Santos E: Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes. Science 1991; 253: 565-568.
21. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593-602.
22. Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M, Land H: Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 1997; 11: 663-677.
23. Liu Y, Martindale JL, Gorospe M, Holbrook NJ: Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res 1996; 56: 31-35.
24. Cheng M, Olivier P, Diehl JA, et al: The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. Embo J 1999; 18: 1571-1583.
25. Medema RH, Kops GJ, Bos JL, Burgering BM: AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000; 404: 782-787.
26. Dijkers PF, Medema RH, Pals C, et al: Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol 2000; 20: 9138-9148.
27. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM: Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999; 398: 630-634.
28. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-185.
29. Kureishi Y, Luo Z, Shiojima I, et al: The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000; 6: 1004-1010.